Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%

Mint has reported a new India-focused policy development: “Trump's tariff policy: Abbott India, Ajanta Pharma to Alembic — pharma stocks crash up to 4%.” The publisher's feed describes the story as follows: Pharma stocks dipped on July 24 after President Trump announced a phased tariff plan for imported generic medicines, raising concerns for Indian exporters. Abbott India led losses at 3.69%, prompting fears over the future of American production and long-term impacts on stocks. Intellectual
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.


